Latest news with #CanaccordGenuity2025MusculoskeletalConference
Yahoo
06-03-2025
- Business
- Yahoo
Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference
Monday, March 10, 2025 at 4:30 pm Pacific Time AUDUBON, Pa., March 05, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it is scheduled to participate in the Canaccord Genuity 2025 Musculoskeletal Conference in San Diego. Management is scheduled to present on Monday, March 10, 2025 at 4:30 pm PT. Interested parties can access the live and archived webcast of the presentation in the 'News & Events', 'Events & Webcasts' section of the Globus Medical investor relations website at About Globus Medical, Inc. Based in Audubon, Pennsylvania, Globus Medical, Inc. is a leading global musculoskeletal technology company dedicated to solving unmet clinical needs and changing lives. We innovate with inspired urgency, provide world-class education and clinical support, and advance care throughout spine, orthopedic trauma, joint reconstruction, regenerative biomaterials and enabling technologies. Additional information can be accessed at Investor contact: Brian Kearns 610-930-1800 investors@ Media contact: Moran Chavez media@ in to access your portfolio
Yahoo
25-02-2025
- Business
- Yahoo
Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference
BEDFORD, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard, President and CEO of Anika, will present at the Canaccord Genuity 2025 Musculoskeletal Conference in San Diego on Monday, March 10, 2025 at 2:30pm PT / 5:30pm ET. Management will also participate in one-on-one investor meetings throughout the event. The presentation will be webcast live on the Events and Webcasts page under the Investors section of Anika Therapeutics' website and will be archived for 30 days following the presentation. For more information about this event or to schedule a one-on-one meeting with Anika's senior management, please contact Anika's Investor Relations at investorrelations@ About AnikaAnika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Leveraging our core expertise in hyaluronic acid and implant solutions, we partner with clinicians to provide minimally invasive products that restore active living for people around the world. Our focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management and Regenerative Solutions, and our products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika's global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit ANIKA, ANIKA THERAPEUTICS, CINGAL, HYALOFAST, INTEGRITY, MONOVISC, ORTHOVISC, TACTOSET, and the Anika logo are trademarks of Anika Therapeutics, Inc. or its subsidiaries or are licensed to Anika Therapeutics, Inc. for its use. For Investor Inquiries:Anika Therapeutics, Hall, 781-457-9554Director, Corporate Development and Investor Relationsinvestorrelations@ in to access your portfolio
Associated Press
17-02-2025
- Business
- Associated Press
Orthofix to Participate in the Canaccord Genuity 2025 Musculoskeletal Conference
LEWISVILLE, Texas--(BUSINESS WIRE)--Feb 17, 2025-- Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that the Company will participate in the Canaccord Genuity 2025 Musculoskeletal Conference in San Diego. Management is scheduled to present on Monday, March 10, 2025 at 9:00 am PT. Interested parties can access the live and archived webcast of the presentation in the 'Events & Presentations' section of the Orthofix investor relations website at Internet Posting of Information Orthofix routinely posts information that may be important to investors in the 'Investors' section of its website at The Company encourages investors and potential investors to consult the Orthofix website regularly for important information about Orthofix. About Orthofix Orthofix is a global medical technology company headquartered in Lewisville, Texas. By providing medical technologies that heal musculoskeletal pathologies, we deliver exceptional experiences and life-changing solutions to patients around the world. Orthofix offers a comprehensive portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH™ navigation system. To learn more, visit and follow on LinkedIn. Julie Dewey, IRC 209.613.6945 SOURCE: Orthofix Medical Inc. Copyright Business Wire 2025. PUB: 02/17/2025 07:05 AM/DISC: 02/17/2025 07:06 AM
